BioRem Inc.
BRM.V · TSXV
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | CA$31,372 | CA$35,746 | CA$41,624 | CA$49,219 |
| - Cash | CA$8,350 | CA$7,655 | CA$9,600 | CA$5,213 |
| + Debt | CA$3,085 | CA$3,140 | CA$3,370 | CA$3,557 |
| Enterprise Value | CA$26,106 | CA$31,231 | CA$35,394 | CA$47,563 |
| Revenue | CA$11,253 | CA$9,431 | CA$4,730 | CA$9,315 |
| % Growth | 19.3% | 99.4% | -49.2% | – |
| Gross Profit | CA$3,166 | CA$2,550 | CA$1,110 | CA$1,597 |
| % Margin | 28.1% | 27% | 23.5% | 17.1% |
| EBITDA | CA$1,746 | CA$1,163 | CA$229 | CA$427 |
| % Margin | 15.5% | 12.3% | 4.8% | 4.6% |
| Net Income | CA$1,158 | CA$745 | CA$37 | CA$171 |
| % Margin | 10.3% | 7.9% | 0.8% | 1.8% |
| EPS Diluted | 0.062 | 0.04 | 0.002 | -0.023 |
| % Growth | 55% | 1,900% | 108.5% | – |
| Operating Cash Flow | CA$901 | -CA$1,336 | CA$4,695 | -CA$1,690 |
| Capital Expenditures | CA$0 | -CA$249 | -CA$91 | -CA$5 |
| Free Cash Flow | CA$902 | -CA$1,585 | CA$4,604 | -CA$1,695 |